• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Programs: Medical Countermeasure (MCM) Readiness


    Medical Countermeasures are life-saving medications and medical supplies that are regulated by the U.S. Food and Drug Administration (FDA). They can be used to alleviate or treat adverse health effects from intentional, accidental, or naturally occurring public health emergencies. Medical Countermeasures can include biologic products such as vaccines and antibodies, drugs such as antimicrobial or antiviral drugs, and devices such as diagnostic tests, personal protective equipment, and ventilators. The Centers for Disease Control and Prevention (CDC) provides technical assistance for developing plans and exercising the ability to receive, distribute, and dispense medical countermeasures. As a part of Medical Countermeasure Readiness, the Cities Readiness Initiative and the Strategic National Stockpile programs were created to further enhance preparedness across the nation and provide a means to receive a variety of Medical Countermeasures quickly in the event of a public health emergency.

    Cities Readiness Initiative (CRI)

    The Cities Readiness Initiative is a federally funded program designed to enhance preparedness in nation’s largest population centers where more than 50% of the United States population resides. The Cities Readiness Initiative started in 2004 with 21 cities and now includes 72 cities and metropolitan statistical areas with at least one Cities Readiness Initiative city in every state. It is funded through the Centers for Disease Control and Prevention's (CDC) Public Health Emergency Preparedness (PHEP) cooperative agreement. The Cities Readiness Initiative jurisdictions work to develop, test, and maintain plans to receive and distribute life-saving medications and medical supplies from the Strategic National Stockpile to local communities following a large-scale public health emergency. Initially, the Cities Readiness Initiative was created specifically for anthrax events, but now includes other public health emergencies. Of Maryland’s 24 local health department​s, 13 of them are Cities Readiness Initiative jurisdictions.

    Strategic National Stockpile (SNS)

    The Strategic National Stockpile is the nation’s largest supply of potentially life-saving pharmaceuticals and medical supplies for use in a public health emergency severe enough to cause local supplies to run out. The stockpile ensures the right medicines and supplies are available when and where needed to save lives. When state, local, tribal, and territorial responders request federal assistance to support their response efforts, the stockpile ensures that medicine and supplies get to those who need them most during an emergency. The Strategic National Stockpile is organized for scalable response to a variety of public health threats. The repository contains enough supplies to respond to multiple large-scale emergencies simultaneously. The Strategic National Stockpile​ program is designed to supplement and resupply state and local inventories of medicines and supplies during emergencies severe enough to exhaust local supplies.